Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Liss

Showing results (191-200 of 256) with videos related to

Pageof 26
Sort By:
Urology|July 21, 2015
Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL ScoreRyan P Kopp, Michael A Liss, Reza Mehrazin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
PURE-MRI: An international study assessing physician accuracy in delineating the prostate and urethra on prostate MRILily Nguyen, Yuze Song, Anna Dornisch, et al.
The Canadian Journal of Urology|April 18, 2016
Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approachesNishant Patel, Jason Woo, Michael A Liss, et al.
The British Journal of Surgery|June 22, 2021
Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancerM Weniger, T Hank, M Qadan, et al.
Urology|February 19, 2013
Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional studySean P Stroup, Omer A Raheem, Kerrin L Palazzi, et al.
Communications Biology|January 8, 2020
Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signalingDinesh Thapa, Shih-Bo Huang, Amanda R Muñoz, et al.
BMC Medical Research Methodology|October 17, 2019
Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk toolsJohanna Tolksdorf, Michael W Kattan, Stephen A Boorjian, et al.
Prostate Cancer and Prostatic Diseases|November 24, 2021
Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trialDharam Kaushik, Pankil K Shah, Neelam Mukherjee, et al.
BJU International|May 30, 2013
Impact of tumour morphology on renal function decline after partial nephrectomyReza Mehrazin, Kerrin L Palazzi, Ryan P Kopp, et al.
The Canadian Journal of Urology|February 18, 2014
Determinants of renal functional decline after open partial nephrectomy: a comparison of warm, cold, and non-ischemic modalitiesRamzi Jabaji, Kerrin L Palazzi, Reza Mehrazin, et al.
Pageof 26

Showing results (191-200 of 256) with videos related to

Sort By:
Pageof 26
Urology|July 21, 2015
Analysis of Renal Functional Outcomes After Radical or Partial Nephrectomy for Renal Masses ≥7 cm Using the RENAL ScoreRyan P Kopp, Michael A Liss, Reza Mehrazin, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|December 18, 2025
PURE-MRI: An international study assessing physician accuracy in delineating the prostate and urethra on prostate MRILily Nguyen, Yuze Song, Anna Dornisch, et al.
The Canadian Journal of Urology|April 18, 2016
Does timing of targeted therapy for metastatic renal cell carcinoma impact treatment toxicity and surgical complications? A comparison of primary and adjuvant approachesNishant Patel, Jason Woo, Michael A Liss, et al.
The British Journal of Surgery|June 22, 2021
Influence of Klebsiella pneumoniae and quinolone treatment on prognosis in patients with pancreatic cancerM Weniger, T Hank, M Qadan, et al.
Urology|February 19, 2013
Does timing of cytoreductive nephrectomy impact patient survival with metastatic renal cell carcinoma in the tyrosine kinase inhibitor era? A multi-institutional studySean P Stroup, Omer A Raheem, Kerrin L Palazzi, et al.
Communications Biology|January 8, 2020
Attenuation of NAD[P]H:quinone oxidoreductase 1 aggravates prostate cancer and tumor cell plasticity through enhanced TGFβ signalingDinesh Thapa, Shih-Bo Huang, Amanda R Muñoz, et al.
BMC Medical Research Methodology|October 17, 2019
Multi-cohort modeling strategies for scalable globally accessible prostate cancer risk toolsJohanna Tolksdorf, Michael W Kattan, Stephen A Boorjian, et al.
Prostate Cancer and Prostatic Diseases|November 24, 2021
Effects of yoga in men with prostate cancer on quality of life and immune response: a pilot randomized controlled trialDharam Kaushik, Pankil K Shah, Neelam Mukherjee, et al.
BJU International|May 30, 2013
Impact of tumour morphology on renal function decline after partial nephrectomyReza Mehrazin, Kerrin L Palazzi, Ryan P Kopp, et al.
The Canadian Journal of Urology|February 18, 2014
Determinants of renal functional decline after open partial nephrectomy: a comparison of warm, cold, and non-ischemic modalitiesRamzi Jabaji, Kerrin L Palazzi, Reza Mehrazin, et al.
Pageof 26